At the news
? NEUTRALIMPACT 2/10 8-K filed Sep 17, 2026 at 15:48 ET
Azenta, Inc. filed an 8-K to disclose the compensation terms for its Interim President and CEO, Dr. Martin D. Madaus, and to report one-time retention awards for four named executive officers. The filing formalizes Dr. Madaus's compensation package and provides retention incentives for key executives, which is a routine administrative matter with no material financial impact on the company.
- Dr. Martin D. Madaus appointed Interim President and CEO effective August 22, 2026; compensation finalized on September 14, 2026.
- Dr. Madaus receives an annual base salary of $600,000 and a cash performance recognition bonus of 100% of base salary, vesting on the first anniversary of the start date.
- Dr. Madaus granted restricted stock units with an award value of $1,200,000, vesting monthly over 12 months.
- One-time retention awards of restricted stock units approved for four named executive officers: Lawrence Lin ($1,000,000), Ephraim Starr ($500,000), Olga Pirogova ($500,000), and Trey Martin ($500,000).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access